HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sekine, Y. Articles by Fujisawa, T. Search for Related Content PubMed PubMed Citation Articles by Sekine, Y. Articles by Fujisawa, T. Related Collections Lung - cancer

Ann Thorac Surg 2003;76:356-361
© 2003 The Society of Thoracic Surgeons

---

Original article: general thoracic

Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease

^a Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan

Accepted for publication March 4, 2003.

^* Address reprint requests to Dr Fujisawa, Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
e-mail: fujisawa{at}med.m.chiba-u.ac.jp

	Abstract

Top Abstract Introduction Patients and methods Results Comment Acknowledgments References

 
BACKGROUND: The aim of this study was to evaluate the influence of chronic obstructive pulmonary diseases (COPD) on postoperative pulmonary function and to elucidate the factors for decreasing the reduction of pulmonary function after lobectomy.

METHODS: We conducted a retrospective chart review of 521 patients who had undergone lobectomy for lung cancer at Chiba University Hospital between 1990 and 2000. Forty-eight patients were categorized as COPD, defined as percentage of predicted forced expiratory volume at 1 second (FEV1) less than or equal to 70% and percentage of FEV1 to forced vital capacity less than or equal to 70%. The remaining 473 patients were categorized as non-COPD.

RESULTS: Although all preoperative pulmonary function test data and arterial oxygen tension were significantly lower in the COPD group, postoperative arterial oxygen tension and FEV1 were equivalent between the two groups, and the ratio of actual postoperative to predicted postoperative FEV1 was significantly better in the COPD group (p < 0.001). With multivariable analysis, COPD and pulmonary resection of the lower portion of the lung (lower or middle-lower lobectomies) were identified as independent factors for the minimal deterioration of FEV1. Actual postoperative FEV1 was 15% lower and higher than predicted, respectively, in the non-COPD patients with upper portion lobectomy and the COPD patients with lower portion lobectomy. Finally, we created a new equation for predicting postoperative FEV1, and it produced a higher coefficient of determination (R²) than the conventional one.

CONCLUSIONS: The postoperative ventilatory function in patients with COPD who had lower or middle-lower lobectomies was better preserved than predicted.

	Introduction

Top Abstract Introduction Patients and methods Results Comment Acknowledgments References

 
Lung cancer and chronic obstructive pulmonary disease (COPD) are common fatal diseases, and lung cancer is far more common in patients with COPD than in those with normal airflow obstruction [1]. It is well known that patients with severe emphysema have a higher risk of postoperative complications than patients without emphysema [2]. However, it has been reported that pulmonary function improved after lobectomy in some severely emphysematous patients [3–5]. Edwards and colleagues [6] have shown that although patients with severe emphysema who fulfilled predicted postoperative forced expiratory volume in 1 second (ppoFEV1) less than 40% of predicted had a significant risk of mortality after lobectomy, actual postoperative FEV1 was not different between patients with ppoFEV1 less than 40% and those with ppoFEV1 more than 40%. We recently reported that even moderate COPD, which was defined as an FEV1 at or below 70% of predicted and an FEV1:forced vital capacity (FVC) ratio at or below 70%, was the absolute risk factor for both postoperative refractory supraventricular arrhythmia and various types of pulmonary complications and poor long-term survival [7, 8]. However, sometimes these patients with moderate emphysema had better postoperative pulmonary function than expected. Because we frequently encounter such lung cancer patients with moderate emphysema, we need to know not only the operative risks but also accurate postoperative residual lung function. Based on the above results, we hypothesized that even in patients with moderate emphysema, lobectomy for lung cancer also has some beneficial effects to suppress functional deterioration of the residual lung similar to effects of volume reduction operation.

To evaluate the functional resectability for lung cancer, the preoperative pulmonary function test (PFT) is still the gold standard, and ppoFEV1 is the most reliable predictor for mortality and morbidity [2, 9]. Although several approaches, such as inhalation perfusion (single-photon emission computed tomography) imaging [10], perfusion lung scintigraphy [11], and quantitative computed tomography [12] have been proposed for predicting precise postoperative FEV1, none of these methods has been proven to be more accurate than the simple calculation based on the number of the bronchopulmonary segments removed. However, recent studies have shown that underestimation of the actual postoperative FEV1 may occur due to heterogeneous distribution of ventilation and perfusion [13].

The purpose of this study was to evaluate the influence of COPD on the change in pulmonary function after lobectomy in lung cancer patients and to elucidate the characteristics of patients with less diminished postoperative pulmonary function in order to establish a more accurate formula for predicting postoperative FEV1.

	Patients and methods

Top Abstract Introduction Patients and methods Results Comment Acknowledgments References

 
We retrospectively reviewed the medical records of 950 patients with non-small cell lung cancer who underwent thoracotomy and pulmonary resection between January 1990 and March 2000 at Chiba University Hospital. Of those, 816 lobectomies, 63 pneumonectomies, 20 segmentectomies, 40 partial lung resections, and 11 combined resections with lungs and major organs were performed. We focused on the 816 lobectomy cases because the anatomic and physiologic changes of residual lungs on the operative side were thought to be most influential to postoperative pulmonary function. Furthermore, to exclude cases with bronchial stenosis or atelectasis, 147 central type lung cancers or cases accompanied by subsegmental or wider atelectasis and 103 cases with tumor diameter exceeding 5 cm were all excluded. These cases were excluded because the predicted postoperative pulmonary function was expected to differ greatly from the actual function because of the nonfunctioning lung. Of the remaining 566 cases, postoperative pulmonary function data were not available in 45 cases because of severe postoperative pulmonary complications; therefore, they were excluded from the analysis. Finally, 521 cases with PFT data for pulmonary function tests and blood gas analyses preoperatively and 1 month postoperatively were entered into this study. Preoperative evaluation for all patients otherwise included a detailed history and physical examination, complete blood cell count, serum electrolytes and renal profile, spirometry, and a 12-lead electrocardiogram. Spirometry was repeated three times, and the highest value was adopted. All current smokers were instructed to cease smoking at the first visit to our hospital, and PFT was repeated immediately before the operation. After discharge from the hospital, we confirmed continuous smoking cessation in all patients postoperatively at least for 3 months by questioning the patients and their families at every visit to the outpatient clinic.

Airway obstruction was defined as percentage of predicted forced expiratory volume in 1 second (percent predicted FEV1) at or below 70% and FEV1:FVC at or below 70% [7, 14]. FEV1 and FEV1:FVC were independent predictors of all cause or respiratory disease mortality [15]. These two variables were used to grade the severity of obstructive abnormalities. In the American Thoracic Society statement [16], when FEV1:FVC is below the normal range (less than 70% to 80% of predicted), percent predicted FEV1 less than 70% was recognized as moderate COPD and less than 50% as severe. Therefore, the criterion of this study was defined as moderate. No bronchodilator was used at PFT. Forty-eight patients fulfilled this criterion (COPD group), and the other 473 were categorized as non-COPD. Only 7 patients had less than 50% of preoperative predicted FEV1, and 1 patient had critically severe emphysema with 0.76 L (27.6% of predicted) of preoperative FEV1. Incentive spirometry was used routinely for enhancing lung expansion 2 weeks before and after the operation. Preoperative pulmonary rehabilitation for COPD patients was done from the time of admission to operation (approximately 2 weeks). If PFT data fulfilled the COPD criterion, preoperative PFT was repeated after the respiratory rehabilitation for the final classification.

We estimated ppoFEV1 by using the following equation: ppoFEV1 = preoperative FEV1 x (1 – S x 0.0526), where S = number of resected bronchopulmonary segments [17]. After actual postoperative FEV1 (apoFEV1) was obtained, the ratio of apoFEV1 to ppoFEV1 (apo/ppo FEV1) was calculated. Then, the minimal deterioration of postoperative FEV1 was determined when apo/ppo FEV1 was 1.15 or more, which was the highest 10% in this study population. This cut-off point was determined based on the distribution of apo/ppo FEV1. We created a histogram where the apo/ppo FEV1 was divided every 0.05. The parametric method was not appropriate for analysis because the distribution had two peaks (n = 69 at 1.00 to 1.05 and n = 21 at 1.15 to 1.20). Therefore, the cut-off point was set to the trough (apo/ppo FEV1 = 1.15) between the two peaks.

The clinical record of each patient was reviewed for the following information: age, gender, body mass index, smoking history, concomitant diseases, and postoperative complications. Positive smoking history included any former smokers as well as current smokers. Descriptions of operations were studied for method of thoracotomy and portion of lobectomy. We divided the portion of lobectomy into two groups, upper portion (upper, middle or upper-middle lobectomies) and lower portion (lower or middle-lower lobectomies). Pathologic staging was determined according to the TNM (tumor, node, and metastasis) classification by Mountain [18].

To evaluate the radiologic severity of emphysema, chest conventional or high-resolution computed tomography was reviewed utilizing the semiquantitative method reported by Goddard and colleagues [19]. A total of three slices were obtained from the lung apex to the lung base at the following levels: upper margin of the aortic arch, origin of the middle lobe bronchus, and right lower pulmonary vein. Right and left lungs were evaluated separately. Then each of the six views was classified into five grades as follows: grade 0 = no emphysema, 1 = emphysematous lesions less than 25%, 2 = emphysematous lesions between 25% and 50%, 3 = emphysematous lesions between 51% and 75%, and 4 = emphysematous lesions over 75%. Areas of low attenuation, indicating less than -950 HU (the lowest level of the mean computed tomographic value of normal lung), and vascular disruption were considered to be suggestive of emphysema [19]. The evaluation was performed by three thoracic specialists independently in a blinded fashion, and the final score was calculated as the mean of scores assigned by the three readers.

Finally, we classified all patients into four subgroups according to the results of multivariable analysis, created the new equation for predicted postoperative FEV1, and validated the usefulness of this formula in 142 lung cancer patients who matched the criteria of this study and had lobectomy at our hospital between April 2000 and March 2002.

Statistical analysis
Data were analyzed using the Stat View Version 5.0 (Statistical Analysis Systems; Cary, NC, USA) by a statistician. To compare the differences between the COPD and non-COPD groups, a Mann-Whitney U test was utilized to analyze continuous variables, and the ² test or Fisher exact test to analyze for categorical variables. The correlation between ppoFEV1 and apoFEV1 was calculated by simple linear regression analysis. The Tukey-Kramer multiple comparison was applied for comparing variables among four subgroups. All preoperative and intraoperative variables including gender, age, body mass index, pathologic type and stage, existence of COPD, portion of lobectomy, type of thoracotomy, operative time, and blood loss were entered into a logistic regression model to identify variables that were independently predictive of less deteriorated postoperative FEV1 (apo/ppo FEV1 1.15). A p value less than 0.05 was considered statistically significant.

	Results

Top Abstract Introduction Patients and methods Results Comment Acknowledgments References

 
Preoperative patient characteristics
Patient characteristics are summarized in Table 1. There were more men in the COPD group (95.8%) compared with the non-COPD group (57.7%, p < 0.001). Smoking was significantly more prevalent in the COPD group (p < 0.001). The distribution of age and body mass index were similar between the two groups. There were no statistically significant differences between the groups with respect to preoperative hypertension and cardiac diseases. Although the distribution of pathologic non-small cell lung cancer stage and type of lobectomy were similar between the two groups, distribution of squamous cell carcinoma (p < 0.001) and standard thoracotomy in the methods of thoracotomy (p = 0.013) were more predominant in the COPD group.

View larger version (28K): [in this window] [in a new window]   Fig 1. The ratio of actual postoperative forced expiratory volume in 1 second to predicted postoperative forced expiratory volume in 1 second (apo/ppo FEV1) was higher in the chronic obstructive pulmonary disease (COPD) group than that in the non-COPD group (p < 0.01). (Dotted line = apo/ppoFEV1 = 1.0.)

View this table: [in this window] [in a new window]   Table 3. Multivariable Analysis of Preoperative and Operative Factors for Minimal Deterioration of Postoperative FEV1 (apo/ppo FEV1 1.15)

View larger version (18K): [in this window] [in a new window]   Fig 2. The correlation between actual postoperative forced expiratory volume in 1 second (apoFEV1) and modified predicted postoperative forced expiratory volume in 1 second calculated by the new equation. Modified predicted postoperative forced expiratory volume in 1 second (ppoFEV1) was significantly correlated with apoFEV1 (R2 = 0.619, p < 0.001). (Black diamonds = the value of the modified ppoFEV1 plotted against the apoFEV1 values.)

	Comment

Top Abstract Introduction Patients and methods Results Comment Acknowledgments References

In this study, we clarified that in COPD patients, defined by pulmonary function tests, arterial blood gas data were undiminished and pulmonary function was less diminished when compared to the data from patients with normal airflow obstruction. In particular, FEV1:FVC improved after lobectomy in COPD patients. This phenomenon occurred not only in patients with heterogeneous emphysema but also in those with homogeneous emphysema confirmed by chest computed tomographic evaluation. Furthermore, by multivariable analysis, lobectomy of lower portion (lower lobectomy or middle-lower lobectomies) was an independent factor for inducing the minimal deterioration of postoperative FEV1. Finally, we established a modified formula for predicting postoperative FEV1 based on the bronchopulmonary segments according to the existence of COPD and the portion of lobectomy.

The effects of lung volume reduction are thought to be related to restoration of the elastic recoil of pulmonary parenchyma and improvement of thoracic motion [21, 22]. However, the mechanism of change of pulmonary function in the COPD patients of this study seemed to be different. First, the subjects of this study were not patients with severe emphysema who needed volume reduction operations. Second, both FVC and FEV1 did not increase in the COPD patients. This may be due to removal of functioning lung tissues. Third, lobectomy of the lower portion resulted in better residual lung function compared with upper portion lobectomy. In general, emphysema is more predominant in the upper lobe than in the lower lobe; therefore, the target of lung volume reduction is frequently the apex of the upper lobe. No patient had alpha 1 anti-trypsin deficiency, and there was no emphysema predominant in the lower lobe. We sometimes find occasional anatomic repositioning after upper lobectomy, which causes narrowing of the orifice of lower or middle lobe bronchus [23]. Conversely, lower lobectomy usually has no effect on the remaining upper and middle bronchus. These anatomic differences may have influenced the synchronization of lung and chest wall motion.

After lobectomy, residual lungs overinflate, the diaphragm elevates, the mediastinum shifts to the operative side, and the intercostal space is reduced in order to fill the space of the resected lung. We speculate that the movement and elevation of the diaphragm may be different between postlower lobectomy and postupper lobectomy [24]. To answer this question, we are now conducting a prospective study to determine the cause of good postoperative FEV1 after lobectomy of the lower portion in COPD patients.

This retrospective study has certain limitations. First, preoperative optimization of respiratory reserve in the COPD patients on medications (including antibiotics, bronchodilators, and steroids) and physical rehabilitation are all confounding variables. Because the study was not controlled, these factors were not incorporated into our statistical analysis. Second, the recovery of ventilatory function takes at least 3 to 6 months [25, 26]. In this study, postoperative PFT was measured 1 month after operation, which is earlier than that of other studies [3, 4]. The postoperative lung function might not have been fully recovered at this point. The main cause of loss of forced respiratory maneuvers is restricted thoracic wall motion influenced by wound pain [27]. The severity of postoperative pain depends on the method of thoracotomy and affects pulmonary gas exchange immediately after thoracic operation [28]. However, we found that the method of thoracotomy was not an independent factor influencing the outcome of less diminished FEV1. We speculate that wound pain might not have strongly affected the PFT data in this study. Giordano and associates [11] reported that perfusion lung scintigraphy could predict postlobectomy residual lung function 1 month after operation. Because pulmonary function recovers in a time-dependent manner [25], the postoperative PFT data 1 month after operation may be consistent with the long-term pulmonary function.

Finally, we established a modified equation for predicting postoperative FEV1. If a patient has marginal pulmonary function, such as 800 mL of ppoFEV1, and lower lobectomy is planned, the patient’s modified ppoFEV1 would become 920 mL, which is acceptable for operation. This new equation has a potency of expanding the functional indication of standard operation for lung cancer patients with COPD.

In conclusion, although COPD patients have a higher risk of postoperative complications, the preservation of ventilatory function may be better than predicted. In particular, lobectomy of the lower portion induced minimal deterioration of postoperative FEV1. Therefore, we propose a new equation for predicting individual postoperative FEV1 according to the patient’s pulmonary function and the portion of the lung lobe resected.

	Acknowledgments

Top Abstract Introduction Patients and methods Results Comment Acknowledgments References

 
We thank Eri Sekine, BS, MPH (Data Management and Biostatistics, Wyeth Lederle Japan, Ltd, Tokyo, Japan), for statistical assistance.

	References

Top Abstract Introduction Patients and methods Results Comment Acknowledgments References

 

1. Tockman M.S., Anthonisen N.R., Wright E.C., Donithan M.G. Airway obstruction and the risk for lung cancer. Ann Intern Med 1987;106:512-518.
2. Markos J., Mullan B.P., Hillman D.R., Musk A.W., Antico V.F., Lovegrove F.T. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989;139:902-910.[Medline]
3. Korst R.J., Ginsberg R.J., Ailawadi M., et al. Lobectomy improves ventilatory function in selected patients with severe COPD. Ann Thorac Surg 1998;66:898-902.[Abstract/Free Full Text]
4. Carretta A., Zannini P., Puglisi A., et al. Improvement of pulmonary function after lobectomy for non-small cell lung cancer in emphysematous patients. Eur J Cardiothorac Surg 1999;15:602-607.
5. DeMeester S.R., Patterson G.A., Sundaresan R.S., Cooper J.D. Lobectomy combined with volume reduction for patients with lung cancer and advanced emphysema. J Thorac Cardiovasc Surg 1998;115:681-688.[Abstract/Free Full Text]
6. Edwards J.G., Duthie D.J., Waller D.A. Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema. Thorax 2001;56:791-795.[Abstract/Free Full Text]
7. Sekine Y., Kesler K.A., Behnia M., Brooks-Brunn J.A., Sekine E., Brown J.W. COPD increases the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer. Chest 2001;120:1783-1790.[Abstract/Free Full Text]
8. Sekine Y., Behnia M., Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for non-small cell lung cancer. Lung Cancer 2002;37:95-101.[Medline]
9. Kearney D.J., Lee T.H., Reilly J.J., DeCamp M.M., Sugarbaker D.J. Assessment of operative risk in patients undergoing lung resection—importance of predicted pulmonary function. Chest 1994;105:753-759.[Abstract/Free Full Text]
10. Imaeda T., Kanematsu M., Asada S., et al. Prediction of pulmonary function after resection of primary lung cancer. Utility of inhalation-perfusion SPECT imaging. Clin Nucl Med 1995;20:792-799.[Medline]
11. Giordano A., Calcagni M.L., Meduri G., Valente S., Galli G. Perfusion lung scintigraphy for the prediction of postlobectomy residual pulmonary function. Chest 1997;111:1542-1547.[Abstract/Free Full Text]
12. Wu M.T., Chang J.M., Chiang A.A., et al. Use of quantitative CT to predict postoperative lung function in patients with lung cancer. Radiology 1994;191:257-262.[Abstract/Free Full Text]
13. Sangalli M., Spiliopoulos A., Megevand R. Predictability of FEV1 after pulmonary resection for bronchogenic carcinoma. Eur J Cardiothorac Surg 1992;6:242-245.[Abstract]
14. Buist A.S., Vollmer W.M. Smoking and other risk factors. In: Murray J.F., Nadel J.A., eds. Textbook of respiratory medicine, 2nd ed Philadelphia: WB Saunders, 1994:1259-1287.
15. Foxman B., Higgins I.T.T., Oh M.S. The effects of occupation and smoking on respiratory disease mortality. Am Rev Respir Dis 1986;134:649-652.[Medline]
16. American Thoracic Society Statement. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-1218.[Medline]
17. Juhl B., Frost N. A comparison between measured and calculated changes in the lung functions after operation for pulmonary cancer. Acta Anaesth Scand 1975;57(Suppl):39-45.
18. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.[Abstract/Free Full Text]
19. Goddard P.R., Nicholson E.M., Laszo G., Watt I. Computed tomography in pulmonary emphysema. Clin Radiol 1982;33:379-387.[Medline]
20. Boushy S.F., Helgason A.H., Billing Gyorky F.G. Clinical, physiologic, and morphologic examination of the lung in patients with bronchogenic carcinoma and the relation of the findings to postoperative deaths. Am Rev Respir Dis 1970;101:685-695.[Medline]
21. Fujimoto K., Kubo K., Haniuda M., Matsuzawa Y., Yamada T., Maruyama Y. Improvements in thoracic movement following lung volume reduction surgery in patients with severe emphysema. Internal Med 1999;38:119-125.
22. Sciurba F.C., Rogers R.M., Keenan R.J., et al. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996;334:1095-1099.[Abstract/Free Full Text]
23. Van Leuven M., Claow N. Bronchial obstruction after upper lobectomy: kinked bronchus relieved by stenting. Ann Thorac Surg 1999;68:235-237.[Abstract/Free Full Text]
24. Nonaka M., Kadokura M., Yamamoto S., et al. Analysis of the anatomic changes in the thoracic cage after a lung resection using magnetic resonance imaging. Surg Today 2000;30:879-885.[Medline]
25. Bolliger C.T., Jordan P., Soler M., et al. Pulmonary function and exercise capacity after lung resection. Eur Respir J 1996;9:415-421.[Abstract]
26. Nezu K., Kushibe K., Tojo T., Takahama M., Kitamura S. Recovery and limitation of exercise capacity after lung resection for lung cancer. Chest 1998;113:1511-1516.[Abstract/Free Full Text]
27. Hazelrigg S.R., Landreneau R.J., Boley T.M., et al. The effect of muscle-sparing versus standard posterolateral thoracotomy on pulmonary function, muscle strength, and postoperative pain. J Thorac Cardiovasc Surg 1991;101:394-401.[Abstract]
28. Sekine Y., Miyata Y., Yamada K., et al. Video-assisted thoracoscopic surgery does not deteriorate postoperative pulmonary gas exchange in spontaneous pneumothorax patients. Eur J Cardiothorac Surg 1999;16:48-53.[Abstract/Free Full Text]

This article has been cited by other articles:

				A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur. Respir. J., July 1, 2009; 34(1): 17 - 41. [Abstract] [Full Text] [PDF]

				K. Kushibe, T. Kawaguchi, M. Kimura, M. Takahama, T. Tojo, and S. Taniguchi Influence of the site of lobectomy and chronic obstructive pulmonary disease on pulmonary function: a follow-up analysis Interactive CardioVascular and Thoracic Surgery, May 1, 2009; 8(5): 529 - 533. [Abstract] [Full Text] [PDF]

				K. Kushibe, T. Kawaguchi, M. Kimura, M. Takahama, T. Tojo, and S. Taniguchi Changes in ventilatory capacity, exercise capacity, and pulmonary blood flow after lobectomy in patients with lung cancer - which lobectomy has the most loss in exercise capacity? Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1011 - 1014. [Abstract] [Full Text] [PDF]

				D. R. Subotic, D. V. Mandaric, T. M. Eminovic, M. M. Gajic, N. M. Mujovic, N. D. Atanasijadis, P. P. Dzeletovic, L. D. Andric, B. M. Bulajic, I. D. Dimitrijevic, et al. Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1292 - 1299. [Abstract] [Full Text] [PDF]

				Y. Sekine, Y. Yamada, M. Chiyo, T. Iwata, T. Nakajima, K. Yasufuku, M. Suzuki, and T. Fujisawa Association of Chronic Obstructive Pulmonary Disease and Tumor Recurrence in Patients With Stage IA Lung Cancer After Complete Resection Ann. Thorac. Surg., September 1, 2007; 84(3): 946 - 950. [Abstract] [Full Text] [PDF]

				G. L. Colice, S. Shafazand, J. P. Griffin, R. Keenan, and C. T. Bolliger Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 161S - 177S. [Abstract] [Full Text] [PDF]

				G. Varela, A. Brunelli, G. Rocco, M. F. Jimenez, M. Salati, and T. Gatani Evidence of Lower Alteration of Expiratory Volume in Patients With Airflow Limitation in the Immediate Period After Lobectomy Ann. Thorac. Surg., August 1, 2007; 84(2): 417 - 422. [Abstract] [Full Text] [PDF]

				A. Brunelli, M. Refai, M. Salati, F. Xiume, and A. Sabbatini Predicted Versus Observed FEV1 and DLCO After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods Ann. Thorac. Surg., March 1, 2007; 83(3): 1134 - 1139. [Abstract] [Full Text] [PDF]

				A. Brunelli, F. Xiume, M. Refai, M. Salati, R. Marasco, V. Sciarra, and A. Sabbatini Evaluation of Expiratory Volume, Diffusion Capacity, and Exercise Tolerance Following Major Lung Resection: A Prospective Follow-up Analysis Chest, January 1, 2007; 131(1): 141 - 147. [Abstract] [Full Text] [PDF]

				G. Varela, A. Brunelli, G. Rocco, R. Marasco, M. F. Jimenez, V. Sciarra, J. L. Aranda, and T. Gatani Predicted versus observed FEV1 in the immediate postoperative period after pulmonary lobectomy. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 644 - 648. [Abstract] [Full Text] [PDF]

				S. Baldi and E. Ruffini Reply to the Editor J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 216 - 216. [Full Text] [PDF]

				V. Porziella, A. Cesario, and P. Granone Dor fundoplication after myotomy for achalasia: Useful, unnecessary, or harmful? J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 216 - 217. [Full Text] [PDF]

				K. Kushibe, M. Takahama, T. Tojo, T. Kawaguchi, M. Kimura, and S. Taniguchi Assessment of pulmonary function after lobectomy for lung cancer - upper lobectomy might have the same effect as lung volume reduction surgery. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 886 - 890. [Abstract] [Full Text] [PDF]

				M. J. Licker, I. Widikker, J. Robert, J.-G. Frey, A. Spiliopoulos, C. Ellenberger, A. Schweizer, and J.-M. Tschopp Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann. Thorac. Surg., May 1, 2006; 81(5): 1830 - 1837. [Abstract] [Full Text] [PDF]

				S. Baldi, E. Ruffini, S. Harari, G. C. Roviaro, M. Nosotti, N. Bellaviti, F. Venuta, D. Diso, F. Rea, C. Schiraldi, et al. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1616 - 1622. [Abstract] [Full Text] [PDF]

				A. Brunelli, A. Sabbatini, F. Xiume', M. Al Refai, A. Borri, M. Salati, R. D. Marasco, and A. Fianchini A model to predict the decline of the forced expiratory volume in one second and the carbon monoxide lung diffusion capacity early after major lung resection Interactive CardioVascular and Thoracic Surgery, February 1, 2005; 4(1): 61 - 65. [Abstract] [Full Text] [PDF]

				E. Yildirim The importance of obstructed and unobstructed segments to be resected in predicting postoperative FEV1 Ann. Thorac. Surg., September 1, 2004; 78(3): 1133 - 1134. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sekine, Y. Articles by Fujisawa, T. Search for Related Content PubMed PubMed Citation Articles by Sekine, Y. Articles by Fujisawa, T. Related Collections Lung - cancer